Started: 10/2018
Study Name: Protocol Title: A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of XXX and Prevnar 13™ with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)
Indication: Pneumococcal
Principal Investigators: Luke Anschutz, Paul Bernhardson, Brad Brabec, Steve Russell
COVID-19 and Flu Swab Test Study Contact our Research Coordinator to ask
Phase III Study of live-attenuated respiratory syncytial virus (RSV) vaccine in healthy
Measles, mumps, rubella, varicella vaccine compared with ProQuad, administered in healthy children
24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Health Infants Given 4 Doses at
